Pediatrics international : official journal of the Japan Pediatric Society · 2025
Differences in arteriovenous carboxyhemoglobin in neonates with noninflammatory pulmonary diseases.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nakamura Toshihiko, Hatanaka Daisuke, Fukama Eisuke
Аннотация
BACKGROUND: To retrospectively examine whether differences in arteriovenous carboxyhemoglobin (a-vCOHb) can be used as a marker for evaluating the severity of neonatal lung disease that develops soon after birth.
METHODS: The subjects were 129 newborn neonates who were classified into three groups comprising 48 infants with severe respiratory disorder (group S), 46 with mild-to-moderate respiratory disorder (group M), and 35 in a control group without respiratory disorder (group C). Various parameters including COHb were measured using a blood gas analyzer/oximeter at the time of admission, with sampling of arteries and veins performed at short intervals (within 30 min).
RESULTS: The arterial COHb values were significantly higher in group C than in group S. The a-vCOHb values were significantly higher in groups C and M than in group S. This suggested that a loss of carbon monoxide excretion due to the generation of shunt blood with lung collapse at the alveolar level and a decrease in the total amount of carbon monoxide generated within the lungs resulted in the decrease of a-vCOHb values in group S. Receiver operating characteristic curve analysis of a-vCOHb for predicting the need for respiratory support identified an a-vCOHb cut-off value of 0.3% with a sensitivity of 75% and specificity of 74% (p < 0.001).
CONCLUSION: An a-vCOHb cut-off value of 0.3% may be useful in determining the severity of lung disease in the early neonatal period.
METHODS: The subjects were 129 newborn neonates who were classified into three groups comprising 48 infants with severe respiratory disorder (group S), 46 with mild-to-moderate respiratory disorder (group M), and 35 in a control group without respiratory disorder (group C). Various parameters including COHb were measured using a blood gas analyzer/oximeter at the time of admission, with sampling of arteries and veins performed at short intervals (within 30 min).
RESULTS: The arterial COHb values were significantly higher in group C than in group S. The a-vCOHb values were significantly higher in groups C and M than in group S. This suggested that a loss of carbon monoxide excretion due to the generation of shunt blood with lung collapse at the alveolar level and a decrease in the total amount of carbon monoxide generated within the lungs resulted in the decrease of a-vCOHb values in group S. Receiver operating characteristic curve analysis of a-vCOHb for predicting the need for respiratory support identified an a-vCOHb cut-off value of 0.3% with a sensitivity of 75% and specificity of 74% (p < 0.001).
CONCLUSION: An a-vCOHb cut-off value of 0.3% may be useful in determining the severity of lung disease in the early neonatal period.